What is Quthero?
Quthero is dedicated to transforming wound treatment from passive dressing to active, rapid, and healthy wound management. The company has engineered novel, effective, and safe treatments for a wide spectrum of wounds, including those from cosmetic procedures, surgical interventions, burns, and chronic ulcers. Quthero's patented platform technology facilitates complete epithelial restoration, promoting swift wound closure with minimal scarring. Their innovative wound management gel offers a potent, paradigm-shifting approach, requiring only a single application to address wound complexities and reduce associated risks such as infection, pain, amputation, and mortality.
How much funding has Quthero raised?
Quthero has raised a total of $517K across 2 funding rounds:
Debt
$17K
Other Financing Round
$500K
Debt (2021): $17K with participation from PPP
Other Financing Round (2024): $500K led by Ontario Centre of Innovation
Key Investors in Quthero
Ontario Centre of Innovation
The Ontario Centre of Innovation (OCI) drives the commercialization of cutting-edge research across key market sectors to build the economy of tomorrow and secure Ontario's global competitiveness. OCI fosters the training and development of the next generation of innovators and entrepreneurs and is a key partner with Ontario's industry, universities, colleges, research hospitals, investors and government ministries.
PPP
Public-Private Partnership
What's next for Quthero?
With the recent influx of major strategic investment, Quthero is poised for significant expansion and further development of its patented wound management technology. This enterprise-level funding is expected to accelerate the company's go-to-market strategy, enhance its research and development capabilities, and potentially broaden its product portfolio to address a wider range of wound care needs. The company's focus on rapid, healthy wound healing positions it for substantial growth in the global healthcare market.
See full Quthero company page
